BCM
AMPE

BlueCrest Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BlueCrest Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-329
Closed -$50K – 1563
2018
Q3 		$50K Buy
+329
New +$138K ﹤0.01% 1437
2018
Q2 		– Sell
-1,038
Closed -$1.06M – 1941
2018
Q1 		$1.06M Buy
+1,038
New +$869K 0.03% 472

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

BlueCrest Capital Management's AMPE Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2018, closing a stake of 329 shares — an estimated $50K sold.

BlueCrest Capital Management first reported a position in AMPE in Q1 2018 and held it in 2 quarters. The position peaked at $1.06M in Q1 2018. 89 funds tracked by Wall St. Rank hold AMPE as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 329 Ampio Pharmaceuticals Inc. shares in Q4 2018, an estimated $50K.
  • BlueCrest Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Ampio Pharmaceuticals Inc. position peaked at $1.06M in Q1 2018.
  • 89 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.